Search for:
Author

Olha Demianiuk

Browsing
Olha Demianiuk is a partner in Baker McKenzie's Corporate M&A Practice Group and the head of the Firm's Healthcare Industry Group in Kyiv. She has more than 11 years of experience advising local and international clients on M&A, private equity, equity capital market deals and corporate matters. Most recently Olha has been focusing on the healthcare sector advising clients on transactional, regulatory, commercial and other matters.
In Product Regulation & Liability

Switzerland: Software as a medical device

by , , and 5 Mins Read

In its decision of 12 September 2022, the Swiss Federal Administrative Court confirmed that interpretive software that uses indicators such as calendar days and body temperature to monitor fertile and infertile phases of a menstrual cycle to achieve natural conception or prevent undesired pregnancy, qualifies as a medical device. This means that such software is subject to a conformity certification procedure with a notified body.

In Sanctions

Ukraine: The law on cancelling marketing authorizations due to ties with Russian/Belarusian pharmaceutical manufacturing became applicable

by and 1 Min Read

Baker McKenzie’s Sanctions Blog published the alert titled Ukraine: The law on cancelling marketing authorizations due to ties with Russian/Belarusian pharmaceutical manufacturing became applicable on 24 August 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.

In Belarus

Ukraine: the law on canceling marketing authorizations due to ties with Russian/Belarusian pharmaceutical manufacturing became effective

by and 1 Min Read

Baker McKenzie’s Sanctions Blog published the alert titled Ukraine: the law on canceling marketing authorizations due to ties with Russian/Belarusian pharmaceutical manufacturing became effective on 20 June 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.

In Belarus

Ukraine: Cancellation of marketing authorizations for pharmaceuticals manufactured in Russia or Belarus or held by companies affiliated or otherwise related to those with manufacturing facilities in Russia or Belarus

by and 1 Min Read

Baker McKenzie’s Sanctions Blog published the alert titled Ukraine: Cancellation of marketing authorizations for pharmaceuticals manufactured in Russia or Belarus or held by companies affiliated or otherwise related to those with manufacturing facilities in Russia or Belarus on 25 May 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.

In AML & Financial Services Regulatory

Ukraine: Conducting Business in Ukraine 2021

by , , , , , , , , , , , , and 1 Min Read

This handbook Conducting Business in Ukraine 2021 has been prepared by the attorneys of Baker McKenzie’s Kyiv office as a general guide for companies operating or considering investing in Ukraine. It is intended to present an overview of the key aspects of the Ukrainian legal system and the regulation of business activities in the country